Different angiogenic pathways in human cervical cancers

Gynecologic Oncology

Volumn 68, Issue 1, 1998, Pages 38-44

  Tokumo, Keizo ^a   Kodama, Junichi ^a   Seki, Noriko ^a   Nakanishi, Yoshie ^a   Miyagi, Yasunari ^a   Kamimura, Shigehito ^a   Yoshinouchi, Mitsuo ^a   Okuda, Hiroyuki ^a   Kudo, Takafumi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ANGIOGENESIS; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION; UTERINE CERVIX CANCER;

EID: 0031887781     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4876     Document Type: Article

References (42)

1. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 267:1992;10931-10934.
2. Folkman J. What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst. 82:1990;4-6.
3. Liotta L, Kleinerman J, Saldel G. Quantitative relationships of intravascular tumor cells, tumor vessel, and pulmonary metastases following tumor implantation. Cancer Res. 34:1974;997-1004.
4. Folkman J, Klagsburn M. Angiogenic factors. Science. 235:1987;442-447.
5. Weidner N, Semple J P, Welch W R, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med. 324:1991;1-8.
6. Fidler I J, Ellis L M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 9:1994;185-188.
7. Kuwano M, Ushiro S, Ryuto M, Samoto H, Izumi H, Ito K, Abe T, Nakamura M, Ono M, Kohno K. Regulation of angiogenesis by growth factors. Gann Monogr Cancer Res. 42:1994;113-125.
8. Ishikawa F, Miyazono K, Hellman U, Hannes D, Wernstadt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin C H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial growth factor. Nature. 338:1989;557-562.
9. Ferrara N, Houck K, Jakeman L, Leung D W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 13:1992;18-32.
10. Ferrara N, Leung D W, Cachianes G, Winer J, Henzel W J. Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells. Methods Enzymol. 198:1991;391-405.
11. Houck K A, Ferrara N, Winer J, Cachianes G, Li B, Leung D W. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol. 5:1991;1806-1814.
12. Yeo T, Senger D, Dvorak H, Freter L, Yeo K. Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor). Biochem Biophys Res Commun. 3:1991;1568-1575.
13. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin C H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature. 338:1989;557-562.
14. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S, Fukui K, Ishizawa M, Yamada Y. Nature. 356:1992;668.
15. Sumizawa T, Furukawa T, Haraguchi M, Yoshimura A, Takeyasu A, Ishizawa M, Yamada Y, Akiyama S. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J Biochem. 114:1993;9-14.
16. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S, Yamada Y. Angiogenic activity of enzymes. Nature. 368:1994;198.
17. Miyadera K, Sumizawa T, Haraguchi M, Yoshida H, Konstanty W, Yamada Y, Akiyama S. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res. 55:1995;1587-1590.
18. Kodama J, Hayase R, Okuda H, Yoshinouchi M, Kudo T. Reverse correlation between P-glycoprotein expression and proliferative activity in endometrial adenocarcinoma. Eur J Obstet Gynecol Reprod Biol. 59:1995;45-51.
19. Yan Z, Weich H A, Bernart W, Breckwoldt M, Neulen J. Vascular endothelial growth factor (VEGF) messenger ribonucletic acid (mRNA) expression in luteinized human granulosa cells in vitro. J Clin Endocrinol Metab. 77:1993;1723-1725.
20. Fox S B, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter K C, Harris A L. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol. 176:1995;183-190.
21. Macchiarini P, Fontanini G, Hardin M J, Squartini F, Angeletti C A. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet. 340:1992;145-146.
22. Gasparini G, Weidner N, Maluta S, Pozza F, Boracchi P, Mezzetti M, Testolin A, Bevilacqua P. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous cell carcinoma. Int J Cancer. 55:1993;739-744.
23. Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, Asano K, Tokuda T, Aizawa S, Ushigome S. Tumor angiogenesis in prostatic carcinoma with and without bone metastasis: a morphometric study. J Pathol. 168:1992;257-262.
24. Horak E, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris A L. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as an indicator of node metastasis and survival in breast cancer. Lancet. 340:1992;1120-1124.
25. Bremer G L, Tiebosch A TMG, van der Putten H WHM, Schouten H JA, de Haan J, Arends J W. Tumor angiogenesis: an independent prognostic parameter in cervical cancer. Am J Obstet Gynecol. 174:1996;126-131.
26. Dinh T V, Hannigan E V, Smith E R, Hove M J, Chopra V, To T. Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix. Obstet Gynecol. 87:1996;751-754.
27. Wiggins D L, Granai C O, Steinhoff M M, Calabresi P. Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol. 56:1995;353-356.
28. Schlenger K, Hockel M, Mitze M, Schaffer U, Weikel W, Knapstein P G, Lambert A. Tumor vascularity - a novel prognostic factor in advanced cervical carcinoma. Gynecol Oncol. 59:1995;57-66.
29. Rutgers J L, Mattox T F, Vargas M P. Angiogenesis in uterine cervical squamous cell carcinoma. Int J Gynecol Pathol. 14:1995;114-118.
30. Kainz C, Speiser P, Wanner C, Obermair A, Tempfer C, Sliutz G, Reinthaller A, Breitenecker G. Prognostic value of tumor microvessel density in cancer of the uterine cervix stage IB to IIB. Anticancer Res. 15:1995;1549-1552.
31. Nakanishi Y, Kodama J, Yoshinouchi M, Tokumo K, Kamimura S, Okuda H, Kudo T. The expression of vascular endothelial growth factor and transforming growth factor-β associates with angiogenesis in epithelial ovarian cancer. Int J Gynecol Pathol. 16:1997;256-262.
32. Takahashi Y, Clearry K R, Mai M, Kitadai Y, Bucana C D, Ellis L M. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res. 2:1996;1679-1684.
33. Nakanishi, Y, Kodama, J, Tokumo, K, Yoshinouchi, M, Okuda, H, Kudo, T, The expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase associates with angiogenesis in epithelial ovarian cancer, Int J Clin Oncol.
34. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris A L. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res. 55:1995;510-513.
35. Saeki T, Takashima S, Hosokawa S, Moriwaki S, Nagasako K, Masaki T, Salomon D S, Ishitsuka H. Differential expression of platelet-derived endothelial cell growth factor (thymidine phosphorylase) in nonpolypoid and polypoid lesions of the colon. Int J Oncol. 8:1996;1105-1111.
36. Guidi A J, Abu-Jawdeh G, Berse B, Jackman R W, Tognazzi K, Dvorak H F, Brown L F. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst. 87:1995;1237-1245.
37. Eda H, Fujimoto K, Watanabe S, Ura M, Hino A, Tanaka Y, Wada K, Ishituka H. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother Pharmacol. 32:1993;333-338.
38. Kieser A, Weich H A, Brandner G. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene. 84:1992;1875-1887.
39. Shweiki G, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845.
40. Rak J, Mitsuhasi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel R S. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. 55:1995;4575-4580.
41. Asano M, Yukita A, Matsumoto T, Kondo S, Suzuki H. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121. Cancer Res. 55:1995;5296-5301.
42. Miwa M, Nishimura J, Kamiyama T, Ishitsuka H. Conversion of 5′-deoxyfluorouridine to 5-FU by pyrimidine nucleoside phosphorylases in normal and tumor tissues from rodents bearing tumors and cancer patients. Jpn J Cancer Chemother. 14:1987;2924-2929.